CALC
CALC
NASDAQ · Pharmaceuticals

Calcimedica Inc

$0.62
+0.02 (+3.47%)
As of May 9, 2:24 AM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 8 80%
Hold 2 20%
Sell 0 0%
Price Target
Analyst Price Target +5,798.1% upside
Low Target $29.06
Average Target $36.71
High Target $43.55
Current Price $0.62
Current
$0.62
Target
$36.71
$29.06 $36.71 avg $43.55
Scenario Analysis
Bear Case
$29.06
4,569.0%
Low target
Base Case
$36.71
+5,798.1%
Avg target
Bull Case
$43.55
+6,897.1%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$7.20
-91.4% from high
52-Week Low
$0.46
+35.1% from low
Target vs 52W High
$36.71
+409.9% vs high
Next Earnings Report
May 18, 2026
7d
until earnings
EPS Est: $-0.29
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%